Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilucoplan in Severe Generalized Myasthenia Gravis Exacerbations
NCT07215949Phase 3Recruiting
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of zilucoplan in myasthenia gravis (MG). Started Jan 2026; status: recruiting.
02
Drugs
zilucoplan
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT07215949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07215949.